Home Medicine Primary hyperparathyroidism as an extremely rare cause of secondary myelofibrosis in childhood
Article
Licensed
Unlicensed Requires Authentication

Primary hyperparathyroidism as an extremely rare cause of secondary myelofibrosis in childhood

  • Arzu Akyay EMAIL logo , Gülçin Cihangiroglu , Yusuf Özkan , Ugur Deveci , Semiha Bahceci and Ziya Çetinkaya
Published/Copyright: June 8, 2013

Abstract

Primary hyperparathyroidism (PHP) and myelofibrosis are rare entities in childhood. Myelofibrosis secondary to PHP is also extremely rare. We report a 15-year-old boy presented with generalized weakness, vomiting, and pallor. A parathyroid adenoma was detected on the left distal parathyroid gland. PHP was diagnosed together with hepatosplenomegaly and pancytopenia. Bone marrow biopsy revealed grade 3–4 reticulin fibrosis. As early as 2 months after the left distal parathyroidectomy, hematologic parameters improved without any other intervention. His liver and spleen also gradually decreased in size. We concluded that the pancytopenia was as a result of myelofibrosis from PHP.


Corresponding author: Arzu Akyay, Elazıg Training and Research Hospital, Inonu cad, No: 74, Elazıg, Turkey, Phone: +90 424 238 10 00/4040, E-mail:

References

1. Lichtman MA, Tefferi A. Primary myelofibrosis. In: Kaushansky K, Lichtman MA, Beutler E, editors. Williams Hematology, 8th ed. New York: McGraw-Hill, 2010:1388–9.Search in Google Scholar

2. Lim DJ, Oh EJ, Park CW, Kwon HS, Hong EJ, et al. Pancytopenia and secondary myelofibrosis could be induced by primary hyperparathyroidism. Int J Lab Hem 2007;29:464–8.10.1111/j.1365-2257.2006.00877.xSearch in Google Scholar PubMed

3. Levard G, Gaudelus J, Cessans C. Primary hyperparathyroidism in children. Ann Chir 1992;46:653–8.Search in Google Scholar

4. Kollars J, Zarroug AE, van Heerden J, Lteif A, Stavlo P, et al. Primary hyperparathyroidism in pediatric patients. Pediatrics 2005;115:974–80.10.1542/peds.2004-0804Search in Google Scholar PubMed

5. Akyay A, Solmaz OA. Myelofibrosis associated with vitamin D deficiency rickets in an older aged child. Pediatr Hematol Oncol 2012;29:691–3.10.3109/08880018.2012.727064Search in Google Scholar PubMed

6. Nomura S, Ogawa Y, Osawa G, Katagiri M, Harada T, et al. Myelofibrosis secondary to renal osteodystrophy. Nephron 1996;72:683–7.10.1159/000188961Search in Google Scholar PubMed

7. Lotinun S, Sibonga JD, Turner RT. Evidence that the cells responsible for marrow fibrosis in a rat model for hyperparathyroidism are preosteoblasts. Endocrinology 2005;146:4074–81.10.1210/en.2005-0480Search in Google Scholar PubMed

8. Coppolino G, Bolignano D, De Paola L, Giulino C, Manella A, et al. Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. J Investig Med 2011;59:823–8.10.2310/JIM.0b013e318214edf8Search in Google Scholar PubMed

9. Brunner S, Zaruba MM, Huber B, Vallaster M, Assmann G, et al. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow. Exp Hematol 2008;36:1157–66.10.1016/j.exphem.2008.03.014Search in Google Scholar PubMed

10. Greenfield EM, Gornik SA, Horowitz MC, Donahue HJ, Shaw SM. Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Miner Res 1993;8:1163–71.10.1002/jbmr.5650081003Search in Google Scholar PubMed

11. Duarte ME, Carvalho EF, Cruz EA, Lucena SB. Cytokine accumulation in osteitis fibrosis of renal osteodystrophy. Braz J Med Biol Res 2002;35:25–9.10.1590/S0100-879X2002000100004Search in Google Scholar PubMed

12. Ohishi M, Schipani E. PTH and stem cells. J Endocrinol Invest 2011;34:552–6.Search in Google Scholar

13. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 1993;328:171–5.10.1056/NEJM199301213280304Search in Google Scholar PubMed

14. Bhadada SK, Bhansali A, Ahluwalia J, Chanukya GV, Behera A, et al. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy. Clin Endocrinol 2009;70:527–32.10.1111/j.1365-2265.2008.03346.xSearch in Google Scholar PubMed

Received: 2012-12-27
Accepted: 2013-5-14
Published Online: 2013-06-08
Published in Print: 2013-11-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review article
  4. Application of imaging modalities for evaluating neuroblastoma
  5. Images in pediatric endocrinology
  6. Lingual thyroid
  7. Original articles
  8. A levothyroxine dose recommendation for the treatment of children and adolescents with autoimmune thyroiditis induced hypothyroidism
  9. Fasting glucagon-like peptide-1 in patients with overt hyperthyroidism and euthyroid congenital hypothyroidism
  10. Perinatal complications and higher risks of offspring thyroid dysfunction in early childhood of Graves’ disease mothers with euthyroidism
  11. Clinical characteristics and management of cranial diabetes insipidus in infants
  12. Desmopressin administration in children with central diabetes insipidus: a retrospective review
  13. An electronic surveillance system for monitoring the hospital presentation of nutritional vitamin D deficiency in children in Scotland
  14. Frequency and severity of ketoacidosis at onset of autoimmune type 1 diabetes over the past decade in children referred to a tertiary paediatric care centre: potential impact of a national programme highlighted
  15. Vitamin D status is associated with early markers of cardiovascular disease in prepubertal children
  16. Evaluation of bone mineral density in children with type 1 diabetes mellitus
  17. Observational study of diabetes management in type 1 diabetic school-age children during holiday versus school days
  18. Relationship of body mass index and GAD65 antibody status on β-cell secretion at diabetes onset in African-American children
  19. Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus
  20. Concomitant autoantibodies in newly diagnosed diabetic children with transient celiac serology or proven celiac disease
  21. Assessment of user-friendliness of the Norditropin FlexPro for pediatric patients treated with recombinant human growth hormone: results of an open-label user survey
  22. Cognitive impairment and gray/white matter volume abnormalities in pediatric patients with Turner syndrome presenting with various karyotypes
  23. Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR)
  24. Prevalence of metabolic syndrome in obese Chilean children and association with gene variants of the leptin-melanocortin system
  25. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents
  26. Could GSD type I expand the spectrum of disorders with elevated plasma chitotriosidase activity?
  27. Patient reports
  28. Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn
  29. Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism
  30. A novel atypical presentation of insulin autoimmune syndrome (Hirata’s disease) in a child
  31. Diagnosis of septo-optic dysplasia in a neonate with hypernatremia, hypoglycemia, and persistent hypothermia
  32. Speech and language delay in two children: an unusual presentation of hyperthyroidism
  33. Lissencephaly presenting with congenital hypothyroidism
  34. PHEX gene mutation in a Chinese family with six cases of X-linked hypophosphatemic rickets
  35. Primary hyperparathyroidism as an extremely rare cause of secondary myelofibrosis in childhood
  36. A family with Camurati-Engelman disease: the role of the missense p.R218C mutation in TGFbeta1 in bones and endocrine glands
  37. A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1
  38. Central precocious puberty in a girl with Prader-Willi syndrome
  39. Type 1 diabetes mellitus in a patient with homozygous sickle cell anemia
  40. Short communication
  41. No impact of obesity susceptibility loci on weight regain after a lifestyle intervention in overweight children
  42. Letter to the Editor
  43. Reliability and validity of homeostasis model assessment for insulin resistance and β-cell dysfunction in critically ill children with hyperglycemia
Downloaded on 12.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0421/html
Scroll to top button